Novartis

A doctor and a patient look at a tablet in his office.
By  Emily Olsen 11:01 am February 22, 2023
Copenhagen-based digital health company Dawn Health announced a strategic partnership with pharma giant Novartis to develop a chronic condition management platform.  Under the collaboration, Dawn and Novartis will build remote monitoring and management tools for chronic conditions where they see an unmet need and concerns around disease progression, like multiple sclerosis, hypertension,...
Two doctors looking at data on a laptop
By  Emily Olsen 10:23 am July 19, 2022
Anumana, a joint venture between EHR data company nference and the Mayo Clinic, announced last week it had entered a strategic partnership with pharma giant Novartis to develop artificial intelligence tools to detect cardiovascular diseases. The collaboration will focus on deploying AI algorithms that analyze ECGs to find left ventricular dysfunction, which can lead to heart failure, and...
Novartis, DiGA, apps, patient innovation
By  Anna Engberg 05:36 am November 22, 2021
Pharma giant Novartis is looking for creative, digital solutions that sustainably improve German healthcare. The company has annouced the fifth installment of the Digital Health Award, with prize money of €60,000 in total available for winners. The awards presentation takes place in Berlin on 24 March 2022, while the call is open for applications until 30 November 2021. WHAT’S THE IMPACT With the...
Researcher
By  Laura Lovett 10:51 am November 3, 2021
The Digital Medicine Society (DiMe) is teaming up with pharma giants AbbVie, Janssen Research and Development, Novartis, Pfizer and UCB to make nocturnal scratch an endpoint for atopic dermatitis.  Atopic dermatitis, also known as eczema, can lead to nighttime itches and scratching, which impact the quality of a patient's sleep. Recent studies have outlined wearable sensors’ role in helping to...
Novartis
By  Sara Mageit 05:57 am July 16, 2021
NOVARTIS BIOME UK ANNOUNCES SELECTION FOR HEALTHHUB 21 Novartis UK has announced the selected companies for the Novartis BIOME UK HealthHub 21 Challenge, in collaboration with KQ Labs, the data driven health accelerator of the Francis Crick Institute, and LifeArc, the charity helping to turn science into benefits for patients. The four selected companies are Living With, Macusoft, Mendelian and...
Myopia, Dopavision
By  Sara Mageit 06:55 am July 15, 2021
Berlin-based digital therapeutics company, Dopavision has announced the closing of a €12 million Series A financing round to develop its lead product for childhood myopia. Seventure Partners led the round and was joined by Novartis Pharmaceuticals and the company's existing shareholders, Boehringer Ingelheim Venture Fund and Ababax Health. WHY IT MATTERS Myopia is the leading cause of correctable...
Ada Health
By  Sara Mageit 06:08 am June 15, 2021
Berlin-based global health company Ada has signed more than 10 new partnerships with key players across sciences, insurance and health systems, including AXA OneHealth, Santéclair, Novartis, CUF, TAJ Digital Health and Sutter Health. These organisations have opted for this partnership in order to improve patient experiences, leveraging Ada’s enterprise solutions to support the delivery of...
Novartis, Ada Health
By  Sara Mageit 01:52 am May 13, 2021
Berlin-based medical AI company Ada Health has announced the launch of a new partnership with Novartis in order to speed up the diagnosis for patients with immunological diseases and rare conditions. The partnership will see Novartis use Ada Health’s AI-based, clinically validated, symptom assessment and care navigation solutions to help improve the identification and diagnosis of a number of...
Lauri Sippola, CEO of Kaiku, gives a demonstration in his Helsinki office.
By  Laura Lovett 11:25 am April 20, 2021
Kaiku Health, maker of an oncology-focused platform that collected patient-reported outcomes, is teaming up with pharma giant Novartis on a new initiative to help monitor and manage melanoma. The companies will zero in on creating a remote monitoring and support network for patients receiving a specific drug combination, known as BRAF and MEK inhibitors, that aims to treat melanoma. As part of...
digital innovation, Novartis
By  Sara Mageit 05:57 am March 29, 2021
Pharma giant Novartis Pharmaceuticals UK and UK provider of digital healthcare solutions, Cievert has announced a digital innovation partnership. The collaboration will support patient care in rheumatology and dermatology by capturing patient-reported data. The partnership was created via the Novartis BIOME, a project which encourages impactful collaboration in science tech, with a selection...